ABSTRACT
Novel indole-3-heterocycles were designed and synthesized and found to be potent CB1 receptor agonists. Starting from a microsomally unstable lead 1, a bioisostere approach replacing a piperazine amide was undertaken. This was found to be a good strategy for improving stability both in vitro and in vivo. This led to the discovery of 24, which had an increased duration of action in the mouse tail flick test in comparison to the lead 1.
Subject(s)
Heterocyclic Compounds/chemistry , Indoles/chemistry , Receptor, Cannabinoid, CB1/agonists , Thiadiazoles/chemistry , Animals , Drug Design , Heterocyclic Compounds/chemical synthesis , Heterocyclic Compounds/pharmacokinetics , Indoles/chemical synthesis , Indoles/pharmacokinetics , Mice , Microsomes/metabolism , Models, Molecular , Receptor, Cannabinoid, CB1/metabolism , Structure-Activity Relationship , Thiadiazoles/chemical synthesis , Thiadiazoles/pharmacokineticsABSTRACT
Bicyclic piperazine derivatives were synthesized as conformationally constrained analogs of N-alkyl piperazines and were found to be potent CB1 receptor agonists. The CB1 receptor agonist activity was dependent upon the absolute configuration of the chiral center of the bicyclic ring system. Although the conformational constraint did not protect the compounds from metabolism by N-dealkylation, several bicyclic analogs were found to be more potent than the unconstrained lead compound. Compound 8b demonstrated potent antinociceptive activity in vivo.
Subject(s)
Amides/chemistry , Azabicyclo Compounds/chemical synthesis , Bridged Bicyclo Compounds/chemistry , Indoles/chemical synthesis , Piperazines/chemistry , Receptor, Cannabinoid, CB1/agonists , Animals , Azabicyclo Compounds/chemistry , Azabicyclo Compounds/pharmacology , Drug Design , Humans , Indoles/chemistry , Indoles/pharmacology , Mice , Microsomes, Liver/metabolism , Piperazines/chemical synthesis , Piperazines/pharmacology , Receptor, Cannabinoid, CB1/metabolism , Structure-Activity RelationshipABSTRACT
The N-3 position of a series of 3-phenoxypropyl piperidine benzimidazol-2-one analogues was optimised using the predictive power of a CoMFA model. The model was used to prioritise compounds for synthesis culminating in the triazole (+)-24. (+)-24 was found to be a high affinity, potent NOP agonist and demonstrated both antinociceptive and antiallodynic effects when administered iv to rodents.
Subject(s)
Benzimidazoles/chemistry , Models, Molecular , Receptors, Opioid/agonists , Analgesics/chemistry , Animals , Benzimidazoles/pharmacology , Hypnotics and Sedatives/chemistry , Rodentia , Structure-Activity Relationship , Nociceptin ReceptorABSTRACT
In order to investigate the effect of the fixation of the orientations of the two long chains, three types of novel derivatives of scavenger receptor inhibitor 1 were synthesized, and their biological activities were evaluated. Among the novel derivatives, 2,4-bis(octadecanoylamino)benzenesulfonic acid sodium salt (4d) showed the most potent inhibitory activity against the incorporation of 1,1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine perchlorate-labeled acetyl-LDL (DiI-acetyl-LDL) into macrophages. 2,5-Bis(octadecanoylamino)benzenesulfonic acid sodium salt (4c), a regioisomer of 4d, did not exhibit as potent an inhibitory activity as 4d, meaning that the substitution pattern of two long chains on the benzene ring must be important. Compound 4d exhibited 10 times more potent inhibitory activity against the binding of 125I-labeled acetyl-LDL to the surface of macrophages than compound 1.
Subject(s)
Benzenesulfonates/pharmacology , Receptors, Immunologic/antagonists & inhibitors , Animals , Arteriosclerosis/drug therapy , Benzenesulfonates/chemical synthesis , Humans , Inhibitory Concentration 50 , Lipoproteins, LDL/metabolism , Macrophages/metabolism , Molecular Weight , Protein Binding/drug effects , Receptors, Scavenger , Structure-Activity RelationshipABSTRACT
HB-EGF Shedding inhibitors have been expected to become effective medicines for skin diseases caused by the proliferation of keratinocytes. In order to discover novel HB-EGF shedding inhibitors and clarify their structure-activity relationships, 5,6,7,8-tetrahydronaphthylidine-based hydroxamic acid and 5,6,7,8-tetrahydropyrido[3,4-b]pyrazine-based hydroxamic acids have been synthesized. Among the synthesized compounds, the ethoxyethoxy derivative 3o and the methoxypropoxy derivative 3p exhibited much more potent HB-EGF shedding inhibitory activity than CGS 27023A. The structural modification of 5,6,7,8-tetrahydropyrido[3,4-b]pyrazine-based hydroxamic acids enabled us to establish the following structure-activity relationships; the existence of the hydroxamic acid, the sulfonamide, and the phenyl moieties are crucial for a potent HB-EGF shedding inhibitory activity, and the stereochemistry of the alpha carbon of hydroxamic acid is also important. In addition, from the comparison of their HB-EGF shedding inhibitory activities with their MMPs inhibitory activities, we found that the S1' pocket of the responsible enzyme for HB-EGF shedding is deep unlike that of MMP-1.
Subject(s)
Epidermal Growth Factor/antagonists & inhibitors , Hydroxamic Acids/chemistry , Hydroxamic Acids/pharmacology , Pyrazines/chemistry , Pyrazines/pharmacology , Heparin-binding EGF-like Growth Factor , Humans , Hydroxamic Acids/chemical synthesis , Intercellular Signaling Peptides and Proteins , Protease Inhibitors/chemistry , Protease Inhibitors/pharmacology , Pyrazines/chemical synthesis , Stereoisomerism , Structure-Activity Relationship , Sulfonamides/chemical synthesis , Sulfonamides/chemistry , Sulfonamides/pharmacology , Tumor Cells, CulturedABSTRACT
Scavenger receptors have been proven to be implicated in the formation of atherosclerotic lesions. A series of novel derivatives of sulfatides were synthesized, and their inhibitory activities against incorporation of DiI-acetyl-LDL into macrophages were evaluated in order to clarify the structure-activity relationships of sulfatides as a scavenger receptor inhibitor and find out novel inhibitors with synthetic easiness. The chemical modification of the substructures of sulfatides led to the establishment of the following structure-activity relationships; (1) the ceramide moiety can be replaced with another structure bearing two long chains, (2) the galactose moiety can be replaced with another structure or be deleted without a large decrease in the inhibitory activity, (3) the sulfate moiety was crucial, and it was the most preferable functional group for a potent inhibitory activity. The inhibitory activity of (S)-2-octadecanoylamino-2-tetradecylcarbamoyl)ethyl sulfate sodium salt (3a) against incorporation of DiI-acetyl-LDL into macrophages was proven to be based on the inhibition against the binding of acetyl-LDL to the surface of macrophages. We discovered novel scavenger receptor inhibitors with synthetic easiness, such as (S)-2-octadecanoylamino-2-(tetradecylcarbamoyl)ethyl sulfate sodium salt (3a) and 2-octadecanoylamino-1-(octadecanoylaminomethyl)ethyl sulfate sodium salt (13q).
